{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:07:17Z","timestamp":1769944037019,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1054,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13311-020-00984-6","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T16:09:24Z","timestamp":1609949364000},"page":"1713-1723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders"],"prefix":"10.1016","volume":"17","author":[{"given":"Stephen R.","family":"Deputy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-971X","authenticated-orcid":false,"given":"Ann H.","family":"Tilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00984-6_bib1","doi-asserted-by":"crossref","unstructured":"Billnitzer A, Jankovic J. Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2020.","DOI":"10.1007\/s13311-020-00914-6"},{"key":"10.1007\/s13311-020-00984-6_bib2","doi-asserted-by":"crossref","unstructured":"Bledsoe IO, Viser AC, San Luciano M. Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2020.","DOI":"10.1007\/s13311-020-00944-0"},{"key":"10.1007\/s13311-020-00984-6_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajhg.2011.12.003","article-title":"PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome","volume":"90","author":"Heron","year":"2012","journal-title":"Am J Hum Genetics"},{"key":"10.1007\/s13311-020-00984-6_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.wco.0000084233.82329.Oe","article-title":"Pediatric movement disorders","volume":"16","author":"Sanger","year":"2003","journal-title":"Current Opinion in Neurology"},{"key":"10.1007\/s13311-020-00984-6_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1469-8749.1989.tb04003.x","article-title":"The Gross Motor Function Measure","volume":"31","author":"Russell","year":"1989","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","article-title":"Development and reliability of a system to classify gross motor function in children with cerebral palsy","volume":"39","author":"Palisano","year":"1997","journal-title":"Dev. Med. Child Neurol"},{"issue":"1","key":"10.1007\/s13311-020-00984-6_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2474-9-44","article-title":"Reliability of Ashworth and Modified Ashworth scales in children with spastic cerebral palsy","volume":"9","author":"Mutlu","year":"2008","journal-title":"BMC musculoskeletal disorders"},{"key":"10.1007\/s13311-020-00984-6_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pediatrneurol.2008.07.002","article-title":"Movement disorder-childhood rating scale: Reliability and validity","volume":"39","author":"Battini","year":"2008","journal-title":"Pediatric Neurology"},{"key":"10.1007\/s13311-020-00984-6_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.seizure.2013.07.003","article-title":"GLUT1 deficiency syndrome 2013: current state of the art","volume":"22","author":"De Giorgis","year":"2013","journal-title":"Seizure"},{"key":"10.1007\/s13311-020-00984-6_bib10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jnnp-2015-311475","article-title":"Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency","volume":"87","author":"Mochel","year":"2016","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry."},{"key":"10.1007\/s13311-020-00984-6_bib11","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation."},{"key":"10.1007\/s13311-020-00984-6_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1542\/pir.24.2.39","article-title":"Movement disorders in children","volume":"24","author":"Schlaggar","year":"2003","journal-title":"Pediatrics in Review"},{"key":"10.1007\/s13311-020-00984-6_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5334\/tohm.376","article-title":"Treatment of Sydenham's chorea: a review of the current evidence","volume":"7","author":"Dean","year":"2017","journal-title":"Tremor and Other Hyperkinetic Movements"},{"key":"10.1007\/s13311-020-00984-6_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.parkreldis.2005.02.007","article-title":"Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy","volume":"11","author":"Teixeira","year":"2005","journal-title":"Parkinsonism & related disorders"},{"key":"10.1007\/s13311-020-00984-6_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0883073811414058","article-title":"Treatment of Sydenham chorea with intravenous immunoglobulin","volume":"27","author":"Walker","year":"2012","journal-title":"Journal of Child Neurology."},{"key":"10.1007\/s13311-020-00984-6_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/aian.AIAN_481_18","article-title":"Neurodegeneration with brain iron accumulation","volume":"22","author":"Batla","year":"2019","journal-title":"Annals of Indian Academy of Neurology"},{"key":"10.1007\/s13311-020-00984-6_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1474-4422(19)30142-5","article-title":"Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study","volume":"18","author":"Klopstock","year":"2019","journal-title":"The Lancet Neurology"},{"key":"10.1007\/s13311-020-00984-6_bib18","first-page":"4","article-title":"A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients","volume":"9","author":"Rohani","year":"2017","journal-title":"Neurology international"},{"key":"10.1007\/s13311-020-00984-6_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/dmcn.12080","article-title":"An update on the prevalence of cerebral palsy: a systematic review and meta-analysis","volume":"55","author":"Oskoui","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/WCO.0b013e3282f4958b","article-title":"Is cerebral palsy preventable?","volume":"21","author":"Nelson","year":"2008","journal-title":"Curr Opin Neurol."},{"key":"10.1007\/s13311-020-00984-6_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1017\/S001216220500112X","article-title":"Proposed definition and classification of cerebral palsy","volume":"47","author":"Bax","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/dmcn.13363","article-title":"The genetic basis of cerebral palsy","volume":"59","author":"Fahey","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/mds.27655","article-title":"Genetic mimics of cerebral palsy","volume":"34","author":"Pearson","year":"2019","journal-title":"Movement Disord"},{"key":"10.1007\/s13311-020-00984-6_bib24","first-page":"1","article-title":"Dopa-Responsive Dystonia Revisited: Diagnostic Delay, Residual Signs, and Nonmotor Signs","volume":"17","author":"Tadic","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/mds.26598","article-title":"Phenotypic insights into ADCY5-associated disease","volume":"31","author":"Chang","year":"2016","journal-title":"Mov Disord."},{"key":"10.1007\/s13311-020-00984-6_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0883073816635749","article-title":"Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders with Deep Brain Stimulation: A Multicenter Case Series","volume":"31","author":"Dy","year":"2016","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-020-00984-6_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1469-8749.1985.tb14133.x","article-title":"Interobserver agreement in the classification of cerebral palsy","volume":"27","author":"Blair","year":"1985","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/01.WNL.0000117981.35364.1B","volume":"62","author":"Ashwal","year":"2004","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00984-6_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0004-9514(05)70003-9","article-title":"Constraint-induced movement therapy following stroke: a systematic review of randomized controlled trials","volume":"51","author":"Hakkennes","year":"2005","journal-title":"Aust J Physiother"},{"key":"10.1007\/s13311-020-00984-6_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1469-8749.2003.tb00867.x","article-title":"A qualitative analysis of the benefits of strength training for young people with cerebral palsy","volume":"45","author":"McBurney","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib31","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/(SICI)1097-4598(1997)6+<92::AID-MUS7>3.0.CO;2-E","article-title":"Traditional pharmacological treatments for spasticity. Part II: General and regional treatments","volume":"20","author":"Gracies","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1007\/s13311-020-00984-6_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/tropej\/fmh095","article-title":"The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy","volume":"51","author":"Mathew","year":"2005","journal-title":"J Trop Pediatr."},{"key":"10.1007\/s13311-020-00984-6_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0022-510X(93)90154-Q","article-title":"Treatment of spasticity in children with low dose benzodiazepine","volume":"117","author":"Dahlin","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-020-00984-6_bib34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jpeds.2014.01.029","article-title":"Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy","volume":"164","author":"He","year":"2014","journal-title":"J Pediatr"},{"key":"10.1007\/s13311-020-00984-6_bib35","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/(SICI)1097-4598(1997)6+<92::AID-MUS7>3.0.CO;2-E","article-title":"Traditional pharmacological treatments for spasticity. Part II: General and regional treatments","volume":"6","author":"Gracies","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"10.1007\/s13311-020-00984-6_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2005.05.001","article-title":"Pharmacotherapy of Spasticity in Children with Cerebral Palsy","volume":"34","author":"Verrotti","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib37","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1177\/0883073808319074","article-title":"Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity","volume":"23","author":"Dai","year":"2008","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-020-00984-6_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/11316090-000000000-00000","article-title":"Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment","volume":"11","author":"Henney","year":"2009","journal-title":"Paediartr Drugs"},{"key":"10.1007\/s13311-020-00984-6_bib39","first-page":"304","article-title":"Medical treatment for spasticity in children with cerebral palsy","volume":"2","author":"Nogen","year":"1976","journal-title":"Childs Brain"},{"key":"10.1007\/s13311-020-00984-6_bib40","first-page":"384","article-title":"Dantrolene sodium in children with spasticity","volume":"55","author":"Haslam","year":"1974","journal-title":"Arch Phys Med Rehab"},{"key":"10.1007\/s13311-020-00984-6_bib41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1469-8749.1980.tb03742.x","article-title":"Dantrolene sodium suspension in treatment of spastic cerebral palsy","volume":"22","author":"Joynt","year":"1980","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpn.2015.09.007","article-title":"Gabapentin can significantly improve dystonia severity and quality of life in children","volume":"20","author":"Liow","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib43","series-title":"Spasticity: Etiology, Evaluation, Management, and the Role of Botulinum Toxin","first-page":"110","article-title":"Botulinum toxin type A: Pharmacology","author":"Brin","year":"2002"},{"key":"10.1007\/s13311-020-00984-6_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1469-8749.1997.tb07408.x","article-title":"Botulinum toxin A in the hemiplegic upper limb: a double-blind trial","volume":"39","author":"Corry","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib45","doi-asserted-by":"crossref","first-page":"e20152830","DOI":"10.1542\/peds.2015-2830","article-title":"AbobotulinumtoxinA for equinus foot deformity in cerebral palsy: A randomized controlled trial","volume":"137","author":"Delgado","year":"2016","journal-title":"Pediatrics"},{"issue":"Suppl 5","key":"10.1007\/s13311-020-00984-6_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1468-1331.2001.00038.x","article-title":"The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial","volume":"8","author":"Love","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1191\/0269215505cr859oa","article-title":"The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling","volume":"19","author":"Steenbeek","year":"2005","journal-title":"Clin Rehabil"},{"key":"10.1007\/s13311-020-00984-6_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1067\/mpd.2000.108393","article-title":"An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy","volume":"137","author":"Fehlings","year":"2000","journal-title":"J Pediatr"},{"key":"10.1007\/s13311-020-00984-6_bib49","first-page":"116","article-title":"Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial","volume":"42","author":"Barwood","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib50","series-title":"Spasticity and Other Forms of Muscle Overactivity in the Upper Motor Neuron Syndrome: Etiology, Evaluation, Management, and the Role of Botulinum Toxin","first-page":"179","article-title":"Cerebral Palsy: A Rational Approach to a Treatment Protocol, and the Role of Botulinum Toxin in Treatment","author":"Russman","year":"2008"},{"key":"10.1007\/s13311-020-00984-6_bib51","first-page":"S37","article-title":"Medium-term Response Characterization and Risk Factor Analysis of Botulinum Toxin Type A in the Management of Spasticity in Children with Cerebral Palsy","volume":"6","author":"Boyd","year":"1999","journal-title":"Eur J Neurol"},{"issue":"suppl 4","key":"10.1007\/s13311-020-00984-6_bib52","first-page":"S11","article-title":"The Use of Botulinum Toxin Type A in Children with Cerebral Palsy: A Retrospective Study","volume":"6","author":"Delgado","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib53","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1001\/jama.1993.03510200081036","article-title":"Continuous intrathecal baclofen infusion for spasticity of cerebral origin","volume":"270","author":"Albright","year":"1993","journal-title":"JAMA"},{"key":"10.1007\/s13311-020-00984-6_bib54","first-page":"1","article-title":"The Impact of Intrathecal Baclofen Therapy on Health-related Quality of Life for Children with Marked Hypertonia","volume":"28","author":"Stewart","year":"2020","journal-title":"Dev Neurorehabil."},{"key":"10.1007\/s13311-020-00984-6_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/088307380001500201","article-title":"Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial","volume":"15","author":"Gilmartin","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib56","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3171\/jns.1998.88.6.1009","article-title":"Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy","volume":"88","author":"Gerszten","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-020-00984-6_bib57","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/apmr.2002.36068","article-title":"Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications","volume":"83","author":"Murphy","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1007\/s13311-020-00984-6_bib58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1469-8749.1998.tb15455.x","article-title":"Electrophysiological monitoring during selective dorsal rhizotomy, and spasticity and GMFM performance","volume":"40","author":"Hays","year":"1998","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13311-018-00690-4","article-title":"The evolution of selective dorsal rhizotomy for the management of spasticity","volume":"16","author":"Nicolaas Enslin","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-020-00984-6_bib60","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/j.wneu.2018.12.187","article-title":"Surgical outcome of single-level bilateral selective dorsal rhizotomy for spastic diplegia in 150 consecutive patients","volume":"125","author":"Jeffery","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1007\/s13311-020-00984-6_bib61","unstructured":"Miller F: Surgical techniques. In Miller F (ed): Cerebral Palsy New York: Springer Science + Business Media, Inc., 2005. pp 865-1024."},{"key":"10.1007\/s13311-020-00984-6_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1302\/1863-2548.14.190127","article-title":"Developmental and conservative treatment of spinal deformities in cerebral palsy","volume":"14","author":"Brunner","year":"2020","journal-title":"J Child Orthop"},{"key":"10.1007\/s13311-020-00984-6_bib63","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1474-4422(17)30252-1","article-title":"Clinical presentation and management of dyskinetic cerebral palsy","volume":"16","author":"Monbaliu","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib64","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/mds.21747","article-title":"Delayed-onset dystonia due to perinatal asphyxia: a prospective study","volume":"22","author":"Cerovac","year":"2007","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00984-6_bib65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/dmcn.13652","article-title":"Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy:a systematic review","volume":"60","author":"Fehlings","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.1965.03080100015003","article-title":"Diazepam in Incapacitating Cerebral Palsied Children","volume":"191","author":"Marsh","year":"1965","journal-title":"Journal American Medical Association"},{"key":"10.1007\/s13311-020-00984-6_bib67","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0883073807302601","article-title":"Child Motor Study Group. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy","volume":"22","author":"Sanger","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib68","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mds.10118","article-title":"Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis","volume":"17","author":"Chatterjee","year":"2002","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00984-6_bib69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-8749.2008.03170.x","article-title":"Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy","volume":"51","author":"Vles","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1586\/14737175.6.1.7","article-title":"Tetrabenazine in the treatment of hyperkinetic movement disorders","volume":"6","author":"Kenney","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1007\/s13311-020-00984-6_bib71","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1017\/S0012162201001190","article-title":"Intrathecal baclofen for generalized dystonia","volume":"43","author":"Albright","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1007\/s13311-020-00984-6_bib72","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00701-009-0281-x","article-title":"Deep brain stimulation for secondary dystonia: results in 8 patients","volume":"151","author":"Katsakiori","year":"2009","journal-title":"Acta Neurochir (Wien)."},{"key":"10.1007\/s13311-020-00984-6_bib73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(09)70151-6","article-title":"French SPIDY-2 Study Group. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study","volume":"8","author":"Vidailhet","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1007\/s13311-020-00984-6_bib74","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/dmcn.14555","article-title":"Deep brain stimulation reduces pain in children with dystonia, including in dyskinetic cerebral palsy","volume":"62","author":"Perides","year":"2020","journal-title":"Dev Med Child Neurol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00984-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00984-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00984-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:03:42Z","timestamp":1761807822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1878747923012680"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00984-6","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00984-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}